OBJECTIVE:
The California Maternal Quality Care Collaborative (CMQCC) recently published a cardiovascular disease (CVD) toolkit for identification of CVD in pregnant/postpartum women. We aim to obtain a baseline screen positive rate and delineate the true positives among women who screened positive. STUDY DESIGN: This is a cross-sectional study from a convenience sample of patients presenting for pregnancy care between April 2018 and July 2018 at University of California, Irvine. Subjects were screened at least once, either during pregnancy or postpartum period. Patients screened positive if they exhibited: 'Red Flags' , had history of prior CVD, or a combination of moderate risk factors (Figure 1) . Patients who screened positive underwent further testing. The primary outcome was the screen positive rate (Table 1) . Secondary outcomes were the "true positive" rate and the strength of each of the moderate factors in predicting CVD. Univariate logistic regression was used to analyze data. RESULTS: 319 women were screened (228 antepartum/intrapartum; 73 postpartum). Only 2.5% of the cohort was African American, 53% was Hispanic, with a large remainder being Caucasian. Overall, 17 (5.3%) patients screened positive and 4 (1.3%) were identified as "true positives" upon further evaluation, i.e. evidence of cardiac disease. Red flags and prior CVD history constituted 9 of 17 screen positive cases; 2 of 4 "true positive" cases were identified from these factors. No patients screened positive by physical exam criteria. Moderate risk factors identified 11 of 17 screen positive cases; 3 of 4 true positives would have been identified based on moderate factors. Table 1 illustrates predictive potential of the moderate factors for a screen positive result. CONCLUSION: CVD is the leading cause of maternal mortality 1 , and 25% of these are preventable.
2-4 We report preliminary findings of the baseline CVD screen positive rate and the true positive rate in an obstetrical population at a tertiary care center. Additionally, we identified the most relevant moderate factors, which may allow modification of the toolkit. Limitations include small sample size and underrepresentation of African Americans. These data may be utilized to design a larger multicenter investigation to validate the CVD algorithm.
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